Skip to main content

Session Coverage

September 23, 2020
“I hope and I think that complex lesion means the same to all operators,” said Dr. Luis Mariano Palena, MD, director of endovascular surgery at Maria Cecilia Hospital in Cotignola, Italy.
September 23, 2020
During a late-breaking clinical trial session at AMP 2020 Virtual, Dr. Michael Lichtenberg, MD, from the Arnsberg Vascular Clinic in Arnsberg, Germany, presented an update of the PRELUDE-BTK study, a feasibility study of the new Serranator PTA…
September 23, 2020
Crossing a chronic total occlusion (CTO) can be tricky, but it’s an important skill set, said Fadi A. Saab, MD, from Advanced Cardiac & Vascular Centers for Amputation Prevention in Grand Rapids, MI, given that CTO rates range from 50% to 60%,…
September 23, 2020
Market analysis suggest that the peripheral atherectomy market in the US and globally is a healthy and growing one, said Eric Secemsky, MD, MSc, the director of vascular intervention at Beth Israel Deaconess Medical Center in Boston, Massachusetts,…
September 23, 2020
Acute compartment syndrome is an important complication of peripheral intervention and one that requires quick diagnosis and treatment, said Eric Scott, MD, at the start of his AMP 2020 Virtual talk entitled, “When Faced with Compartment Syndrome,…
September 03, 2020
"The FDA currently recommends well-conducted randomized controlled trials (RCTs) using concurrent control and objective endpoints for critical limb ischemia (CLI) trials," said Eleni Whatley, PhD, a lead reviewer on the Plaque Modification Devices…
September 03, 2020
Bret N. Wiechmann, MD, from Vascular and Interventional Physicians in Gainesville, Florida, discusses how cost and reimbursement remain the biggest issues impacting DCB and DES use in the office-based lab.
September 03, 2020
Ankur Lohda, MD, from the Cardiovascular Institute of the South in Lafayette, LA, gave a virtual talk at AMP 2020 and provided attendees with an update on radial artery access for peripheral intervention, reporting data from the REACH PVI trial.
August 14, 2020
During a late-breaking trials session at AMP 2020 Virtual, Marianne Brodmann, MD, from the Medical University of Graz, Graz, Austria, presented 12-month findings and 3-year safety analyses for the Lutonix BTK IDE study. Read more for Dr. Brodmann's…
August 14, 2020
There were a number of technical realities that compelled Jihad Mustapha, MD, to move his CLI practice out of a hospital setting and start his own center dedicated to limb salvage, but the real driver was his dedication to the treatment of patients…
Back to Top